Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111732542A details a novel chiral ligand synthesis. We offer scalable manufacturing, cost reduction in asymmetric catalysis, and reliable supply chain solutions.
Patent CN109232333B reveals a metal-free method for benzenesulfonyl enamines using iodine catalysis. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN108484517B reveals a metal-free benzoxazole synthesis using NHPI and air. Discover cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Efficient synthesis of key agrochemical intermediates via solvent-free decarboxylation. Reduces waste and improves yield for pharmaceutical manufacturing.
Patent CN117701523A reveals solvent-tolerant transaminase for high-purity sitagliptin intermediate manufacturing with significant supply chain cost reduction.
Patent CN114105722A reveals a metal-free fluorination method using SO2F2 gas. Discover cost-effective strategies for high-purity pharmaceutical intermediates manufacturing.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN101560171A reveals a novel synthesis for 5-DNSA. Achieve superior purity and yield for Labetalol production with our scalable pharmaceutical intermediates supply chain solutions.
Novel base-promoted synthesis offers significant cost reduction and scalability for high-purity xanthone manufacturing supply chains globally ensuring reliable procurement.
Patent CN113061594A reveals novel immobilized transaminase mutants for sitagliptin synthesis, offering superior stability in aqueous isopropanol and reduced manufacturing costs.
Patent CN113061594A details a robust immobilized transaminase process for sitagliptin intermediates, offering superior stability and simplified solvent systems for cost-effective API manufacturing.
Patent CN110218758A reveals enzymatic lutein ester synthesis offering high purity and mild conditions for reliable pharmaceutical intermediate supply chain optimization.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Novel synthesis of (S,E)-1,9-diene-4,6-diyne-3-octadecyl alcohol offers high purity and cost efficiency for pharmaceutical intermediate supply chains globally.
Advanced vanadium catalysis patent CN106380429A enables high-purity pharmaceutical intermediate manufacturing with reduced waste and optimized supply chain reliability for global buyers.
Novel alkaline trihalogenation process for 17-formic acid steroids offers high yield, purity, and reduced toxicity for API manufacturing.
Patent CN106397117A details a novel enzymatic resolution process yielding high-purity chiral alcohols with significant supply chain and cost advantages for global buyers.
Explore CN1087337A technology for leukotriene inhibitors. We offer reliable pharmaceutical intermediates supplier services with optimized etherification and alkylation routes.
Patent CN110305071A details high-yield SC 69124 synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN108147946A reveals a cost-effective iron reduction route for 4-phenylphenol, offering supply chain stability and purity advantages for agrochemical manufacturing.